Dentsply Sirona 2026 Q1: APAC Net Sales $115 Million, Up 6.3% Year-over-Year

Source: Dentsply Sirona Q1 2026 Financial Performance Report

Net Loss Attributable to Shareholders of the Parent Company of $10 Million / Gross Margin Declines to 48.5% / APAC Revenue Down 8.1%

DentalGoodNews｜On May 5, 2026, Dentsply Sirona announced its financial results for the first quarter of 2026 (ended March 31, 2026). During the reporting period, the company achieved net sales of $880 million (approximately RMB 6.010 billion), a year-over-year increase of 0.1%. Net Profit Attributable to Shareholders of the Parent Company recorded a net loss of $10 million (approximately RMB 68.3 million), compared to a profit of $20 million (approximately RMB 137 million) in the same period last year.

On a Non-Generally Accepted Accounting Principles (Non-GAAP) basis, the company's adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) for the first quarter was $129 million (approximately RMB 881 million), down 22.8% year-over-year, with the adjusted EBITDA margin declining to 14.7% from 19.0% in the same period last year. Adjusted Net Profit Attributable to Shareholders of the Parent Company was $54 million (approximately RMB 369 million), and Adjusted Earnings Per Share (Adjusted EPS) was $0.27 (approximately RMB 1.84), down approximately 39% year-over-year.

Source: Dentsply Sirona Q1 2026 Financial Performance Report

In terms of gross margin, Dentsply Sirona's Generally Accepted Accounting Principles (GAAP) gross margin fell to 48.5% from 53.0% in the same period last year. The adjusted gross margin was 50.7%, also lower than the level in the same period last year. The company's CEO, Dan Scavilla, stated that the company is progressing as planned with its "Return-to-Growth Action Plan." Current performance is still impacted by external pressures and investment pacing, but management remains confident in restoring sustainable growth in the future. According to previous reports from DENTALGOODNEWS (Leading Dental Industry Media, DGN), Dentsply Sirona initiated this strategy starting in the third quarter of 2025, focusing on commercial restructuring, channel optimization, and product innovation.

Source: Dentsply Sirona Q1 2026 Financial Performance Report

By business segment, Connected Technology Solutions contributed revenue of $246 million (approximately RMB 1.680 billion), up 4.4% year-over-year, primarily driven by the expansion of distribution channels. During the period, the company launched the world's first FDA｜Food and Drug Administration (FDA)-approved Cone Beam Computed Tomography (CBCT) diagnostic tool with AI capabilities, Smart View-Detect, which has also received CE certification in Europe. Essential Dental Solutions revenue was $350 million (approximately RMB 2.391 billion), a slight decrease of 0.9%. Orthodontic and Implant Solutions revenue was $199 million (approximately RMB 1.359 billion), down 8.1% year-over-year. The Wellspect Healthcare business achieved 15% growth, with revenue reaching $85 million (approximately RMB 581 million).

By region, Dentsply Sirona adopted a new regional reporting structure starting this fiscal quarter, covering the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC). Among these, net sales in the Americas were $330 million (approximately RMB 2.254 billion), down 9.4% year over year; net sales in the EMEA region were $435 million (approximately RMB 2.971 billion), up 6.9% year over year; and net sales in the APAC region were $115 million (approximately RMB 785 million), up 6.3% year over year. On a constant currency basis, the three regions declined 10.7%, declined 5.6%, and grew 2.7%, respectively. The company stated that the new regional structure will better align with its internal commercial management structure.

Source: Dentsply Sirona Q1 2026 Financial Performance Report

In terms of cash flow and balance sheet, the company's operating cash flow for the first quarter was $40 million (approximately RMB 273 million), a significant improvement from $7 million (approximately RMB 47.81 million) in the same period last year, primarily benefiting from optimized Accounts Receivable collections. However, due to capital expenditures of $52 million (approximately RMB 355 million), free cash flow was negative $12 million (approximately RMB 81.96 million). As of March 31, 2026, the company held cash and cash equivalents of $190 million (approximately RMB 1.298 billion), down from $326 million (approximately RMB 2.227 billion) at the end of 2025.

Looking ahead to the full year 2026, Dentsply Sirona maintains its previous guidance, expecting full-year net sales to be between $3.5 billion and $3.6 billion (approximately RMB 23.905 billion to RMB 24.588 billion), and Adjusted EPS to be between $1.40 and $1.50 (approximately RMB 9.56 to RMB 10.25). Management stated that it will continue to advance strategies for debt reduction, liquidity management, and working capital optimization.